Akhtar Naveed, Kamran Saadat, Singh Rajvir, Malik Rayaz A, Deleu Dirk, Bourke Paula J, Joseph Sujatha, Santos Mark D, Morgan Deborah M, Wadiwala Faisal M, Francis Reny, Babu Blessy M, George Pooja, Ibrahim Rumissa, Garcia-Bermejo Pablo, Shuaib Ashfaq
The Stroke Program, The Neuroscience Institute, Hamad Medical Corporation, Doha, Qatar.
Department of Cardiology, Hamad Medical Corporation, Qatar.
J Stroke Cerebrovasc Dis. 2019 Mar;28(3):619-626. doi: 10.1016/j.jstrokecerebrovasdis.2018.11.003. Epub 2018 Dec 10.
Stroke in diabetics may delay recovery and increases the risk of early recurrence of stroke. We compared the outcomes of patients (with and without diabetes) admitted with an acute ischemic stroke (AIS) in the state of Qatar.
We prospectively compared the clinical presentation, complications, discharge outcome, and stroke recurrence at 90 days in patients with and without diabetes.
Five thousand two hundred twenty-eight stroke patients were admitted between January 2014 and December 2017. Two thousand nine hundred sixty-one had confirmed AIS, 1695 (57.2%) had diabetes, 429 (14.5%) had prediabetes and 873 (29.5%) had no diabetes. Comparing diabetic patients to prediabetic and nondiabetics, they were significantly older (58.5 ± 11.9 versus 54.0 ± 12.9 versus 49.5 ± 13.8, P = .0001), had higher rates of hypertension (80.8% versus 67.4% versus 59.2%), previous stroke (18.0% versus 5.4% versus 6.2%), and coronary artery disease (12.9% versus 5.6% versus 5.0%; P = .001 for all). The percentage of patients with modified Rankin scale 3-6 at discharge (39.7% versus 32.6% versus 30.2%; P = .0001) and 90 days (26.7% versus 18.8% versus 21.4%, P = .001); 90-day mortality (6.2% versus 2.2% versus 5.2%; P = .03) and stroke recurrence (4.2% versus .7% versus 2.2%; P = .005) was significantly higher in diabetic patients.
Patients with diabetes and AIS have more in-hospital complications, worse discharge outcomes, higher mortality and stroke recurrence at 90 days, compared to prediabetes and no diabetes.
糖尿病患者发生中风可能会延迟康复,并增加中风早期复发的风险。我们比较了卡塔尔国急性缺血性中风(AIS)患者(有糖尿病和无糖尿病)的治疗结果。
我们前瞻性地比较了有糖尿病和无糖尿病患者的临床表现、并发症、出院结局以及90天时的中风复发情况。
2014年1月至2017年12月期间,共有5228例中风患者入院。其中2961例确诊为急性缺血性中风,1695例(57.2%)患有糖尿病,429例(14.5%)患有糖尿病前期,873例(29.5%)无糖尿病。与糖尿病前期和非糖尿病患者相比,糖尿病患者年龄显著更大(58.5±11.9岁对54.0±12.9岁对49.5±13.8岁,P = 0.0001),高血压、既往中风和冠状动脉疾病的发生率更高(80.8%对67.4%对59.2%;18.0%对5.4%对6.2%;12.9%对5.6%对5.0%;所有P值均为0.001)。出院时改良Rankin量表评分为3 - 6分的患者百分比(39.7%对32.6%对30.2%;P = 0.0001)以及90天时的百分比(26.7%对18.8%对21.4%,P = 0.001);90天死亡率(6.2%对2.2%对5.2%;P = 0.03)和中风复发率(4.2%对0.7%对2.2%;P = 0.005)在糖尿病患者中显著更高。
与糖尿病前期和无糖尿病患者相比,糖尿病合并急性缺血性中风患者住院期间并发症更多,出院结局更差,90天时死亡率和中风复发率更高。